作者：
Byrd,J.C. [1]
;
Furman,R.R. [2]
;
Coutre,S.E. [3]
;
Flinn,I.W. [4]
;
Burger,J.A. [5]
;
Blum,K.A. [6]
;
Grant,B. [7]
;
Sharman,J.P. [8]
;
Coleman,M. [9]
;
Wierda,W.G. ;
Jones,J.A. ;
Zhao,W. ;
Heerema,N.A. ;
Johnson,A.J. ;
Sukbuntherng,J. ;
Chang,B.Y. ;
Clow,F. ;
Hedrick,E. ;
Buggy,J.J. ;
James,D.F. ;
O'Brien,S.
作者单位：
Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH
[1]
Pharmacyclics, Sunnyvale, CA, United States
[2]
Willamette Valley Cancer Institute and Research Center, U.S. Oncology Research, Springfield, OR
[3]
Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College
[4]
Department of Pathology, Ohio State University, Columbus, OH, United States
[5]
Sarah Cannon Research Institute, Nashville, TN, United States
[6]
Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
[7]
Vermont Cancer Center, University of Vermont, Burlington, VT, United States
[8]
Division of Hematology, Stanford Cancer Center, Stanford University School of Medicine, Stanford
[9]
发布时间
2013-11-20
换一批
